Ann: Letter to Shareholders from the Board of Ave, page-25

  1. 388 Posts.
    lightbulb Created with Sketch. 27
    re: Ann: Letter to Shareholders from the Boar... FOTH,

    Fairly certain they did.

    By the way, it is not unusual for a company not to mention a competitor or play it down.

    Again, I heard all of the complaints about ATC by talking to biotech people well before (years) Avexa canned ATC. The only one that wasn't mentioned was the innaproriate size of the 800mg dose for combo therapies. The company must have known that one for a while, though.

    Cheers,

    Bob
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.